Erminio "Mimo" Costa (March 9, 1924 – November 28, 2009) was an Italian-American neuroscientist.^[3] His research interests covered brain serotonergic activity in health and disease, benzodiazepine-GABA interactions,^[4] benzodiazepine action at GABAA receptors, neurophysiological role of neurosteroids,^[5] and GABAergic dysfunction and changes in the expression of reelin and GAD67 in schizophrenia.^[6] He published more than 1,000 articles.^[7] The June 2011 issue of the journal Neuropharmacology was dedicated to him.^[8]

• July 1947 - M.D. 110/110 cum laude, University of Cagliari, Italy
• 1950-1960 - Thudichum Psychiatric Research Laboratory, Galesburg Research Hospital, Galesburg, Illinois
• 1960-1965 - Deputy Chief, Laboratory of Chemical Pharmacology at NHLI - NIH, Bethesda, Maryland
• 1965-1968 - Associate Professor of Pharmacology and Neurology, College of Physicians and Surgeons of Columbia University, New York, NY
• 1968-1985 - Chief of the Laboratory of Preclinical Pharmacology, NIMH, St. Elizabeths Hospital, Washington, DC
• 1985-1994 - Director and Founder, Institute of Neuroscience, and Professor of Pharmacology, Georgetown University, Washington, DC
• 1994-1995 - Director, Center for Neuropharmacology, Nathan Kline Institute for Psychiatric Research, New York University, New York, NY
• 1995 - Scientific Director, Psychiatric Institute, Professor of Biochemistry in Psychiatry, Department of Psychiatry, College of Medicine, University of Illinois at Chicago, Chicago, Illinois
• 1982 - Member, National Academy of Sciences
• 1991 - Member of "Accademia dei Lincei" founded by Galileo Galilei in 1602, Rome

• Advances in Biochemical Psychopharmacology (1969)
• Biochemistry and Pharmacology of the Basal Ganglia (1966)
• Biochemistry of Simple Neuronal Models (1970)
• Neurosteroids and Brain Function (1991)
• The Endorphins - Vol. 18 (1985)

• Bernard Brodie, in whose laboratory Costa worked for a time.